GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Jun 30, 2023

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-23-000029General Corporate
Capex intensity40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.44% · OPTIONAL · VALID

Operating cash generation95thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

9.83% · OPTIONAL · VALID

Revenue growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

12.49% · CORE · VALID

Gross margin95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

16.09% · CORE · VALID

Operating margin100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

6.46% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
0.80%
Current
0.44%
Delta
-0.36%
Cash Generation Increased
Previous
-2.93%
Current
9.83%
Delta
12.76%
Growth Increased
Previous
11.49%
Current
12.49%
Delta
1.00%
Margin Increased
Previous
15.09%
Current
16.09%
Delta
1.00%
Profitability Increased
Previous
5.36%
Current
6.46%
Delta
1.10%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.